These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7397319)

  • 1. Approach to the quantitation of alkylated amino acids in haemoglobin by gas chromatography mass spectrometry.
    Farmer PB; Bailey E; Lamb JH; Connors TA
    Biomed Mass Spectrom; 1980 Jan; 7(1):41-6. PubMed ID: 7397319
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylation of cysteine in hemoglobin following exposure to methylating agents.
    Bailey E; Connors TA; Farmer PB; Gorf SM; Rickard J
    Cancer Res; 1981 Jun; 41(6):2514-7. PubMed ID: 7237445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enantiomer as internal standard for the quantitation of the alkylated amino acid S-methyl-L-cysteine in haemoglobin by gas chromatography-chemical ionisation mass spectrometry with single ion detection.
    Bailey E; Farmer PB; Lamb JH
    J Chromatogr; 1980 Nov; 200():145-52. PubMed ID: 7451605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of alkylated proteins in the monitoring of exposure to alkylating agents.
    Farmer PB; Bailey E; Campbell JB
    IARC Sci Publ; 1984; (59):189-98. PubMed ID: 6545280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macromolecular complexes produced by chemical carcinogens and ultraviolet radiation.
    Morin NR; Zeldin PE; Kubinski ZO; Bhattacharya PK; Kubinski H
    Cancer Res; 1977 Oct; 37(10):3802-14. PubMed ID: 332339
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of genetic risks of alkylating agents IV. Quantitative determination of alkylated amino acids in haemoglobin as a measure of the dose after-treatment of mice with methyl methanesulfonate.
    Segerbäck D; Calleman CJ; Ehrenberg L; Löfroth G; Osterman-Golkar S
    Mutat Res; 1978 Jan; 49(1):71-82. PubMed ID: 202871
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of alkylating agents by the analysis of amino acid residues in hemoglobin and urine. 1. The in vivo and in vitro effects of ethyl methanesulfonate, methyl methanesulfonate, hycanthone methanesulfonate, and naltrexone.
    Truong L; Ward JB; Legator MS
    Mutat Res; 1978 Dec; 54(3):271-81. PubMed ID: 740012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear proteins damage by alkylating agents with different degrees of carcinogenicity.
    Boffa LC; Bolognesi C
    Chem Biol Interact; 1985 Oct; 55(1-2):235-45. PubMed ID: 4064193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The determination of in vivo alkylation of haemoglobin and DNA using gas chromatography-mass spectrometry.
    Farmer PB; Bailey E; Shuker DE
    Dev Toxicol Environ Sci; 1983; 11():273-80. PubMed ID: 6677462
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary excretion of methylated purines and 1-methyl-nicotinamide following administration of methylating carcinogens.
    Shaikh B; Huang SS; Pontzer NJ
    Chem Biol Interact; 1980 May; 30(2):253-6. PubMed ID: 6446418
    [No Abstract]   [Full Text] [Related]  

  • 11. Cysteine adducts of human haemoglobin measured by isoelectric focusing in polyacrylamide gels with a non-linear pH gradient.
    Evelo CT; Niessen HJ; Roelofs HM; Henderson PT
    J Chromatogr; 1987 Sep; 420(1):35-42. PubMed ID: 3667828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric analysis of haemoglobin adducts formed by methyl bromide in vitro.
    Sannolo N; Carbone V; Ferranti P; Fiume I; Mamone G; Malorni A
    J Chromatogr B Biomed Appl; 1995 Aug; 670(2):349-53. PubMed ID: 8548027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of exposure to alkylating carcinogens by the GC-MS determination of adducts to hemoglobin and nucleic acid bases in urine.
    Bailey E; Farmer PB; Shuker DE
    Arch Toxicol; 1987; 60(1-3):187-91. PubMed ID: 3619640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of glutathione on the formation of cysteine alkylation products in human hemoglobin.
    Evelo CT; Henderson PT
    Toxicology; 1988 Nov; 52(1-2):177-86. PubMed ID: 3188031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective alkylation of nucleic acids by carcinogens may cause miscoding in DNA. A theoretical study.
    Klopman G; Ray A
    Cancer Biochem Biophys; 1982; 6(1):31-5. PubMed ID: 7093936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific DNA alkylation damage and its repair in carcinogen-treated rat liver and brain.
    Wani AA; D'Ambrosio SM
    Arch Biochem Biophys; 1986 May; 246(2):690-8. PubMed ID: 3707128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor.
    Osterman-Golkar S; Ehrenberg L; Segerbäck D; Hällström I
    Mutat Res; 1976 Jan; 34(1):1-10. PubMed ID: 1250243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkylation of macromolecules for detecting mutagenic agents.
    Ehrenberg L; Osterman-Golkar S
    Teratog Carcinog Mutagen; 1980; 1(1):105-27. PubMed ID: 6119796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide.
    Calleman CJ; Ehrenberg L; Jansson B; Osterman-Golkar S; Segerbäck D; Svensson K; Wachtmeister CA
    J Environ Pathol Toxicol; 1978; 2(2):427-42. PubMed ID: 739221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of N-7-[2H3]methyl guanine in rat urine by gas chromatography-mass spectrometry following administration of trideuteromethylating agents or precursors.
    Shuker DE; Bailey E; Gorf SM; Lamb J; Farmer PB
    Anal Biochem; 1984 Jul; 140(1):270-5. PubMed ID: 6486413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.